COVID-19 symptoms that don’t go away affect hundreds of millions worldwide. Scripps Research is recruiting people with long ...

PALO ALTO, Calif. -- Researchers at Stanford Medicine have discovered a possible link to the "brain fog" that some COVID-19 patients have experienced. Working with a team in Germany, they found that ...

Researchers are launching a new study to investigate whether GLP-1 drugs, already approved for type 2 diabetes and obesity, could help treat long COVID symptoms.

New research reveals that women with long COVID show distinct biological disruptions — including gut inflammation, anemia, ...

Women are about three times more likely than men to develop long COVID, and many experience symptoms that linger and ...

About 12M long COVID patients have reported 'brain fog' New study examined 17 people, including 10 with neurological symptoms Findings validate the experiences of 'long-haulers' About 12M long COVID ...

GLP-1s are being studied for a wide range of conditions. Now, scientists will test whether their anti-inflammatory properties ...

Scientists may have uncovered an important aspect of long covid. Recent research appears to show that the blood of these ...

While the COVID pandemic has thankfully been over for some time now, there is still a considerable number of people in the world (about 400 million) suffering from long COVID. Long COVID is a chronic ...

It's not available yet, but it could lay the groundwork for faster diagnoses and, potentially, additional treatments.